Skip to main content
. 2022 Jan 11;13(1):51. doi: 10.1038/s41419-022-04500-w

Fig. 1. Relative expression of linc01133 in gastric cancer tissue.

Fig. 1

A RT-qPCR showed that linc01133 expression was upregulated in gastric cancer tissues compared to that in the normal gastric tissues (Mann–Whitney test, p = 0.048). B The expression of linc01133 was upregulated in gastric cancer cells compared to the immortalized normal gastric epithelial cells. C Online tool GEPIA analysis of linc01133 expression combining the TCGA and GTEx database. D, E GEPIA analysis of disease-free survival and overall survival of gastric patients with high (n = 192) and low (n = 192) linc01133 expression. F Schematic illustration of the luciferase vectors containing linc01133 promoter regions. G Luciferase assay confined the core regulatory regions to −502~−265 bp and −72~ +76 bp up-stream of transcriptional start site. H Luciferase assay showed that co-expression of c-JUN and c-FOS significantly increased the pGL3-502 luciferase activity. I Co-expression of c-JUN and c-FOS enhanced linc01133 expression in HEK293T, HGC27, MKN45 and SGC7901 cells but not in AGS cells. J JUN expression in gastric cancer cell lines. K Schematic illustration of the c-JUN-binding sites and the sites of primer pair design for ChIP assay. L–N ChIP-qPCR analyses showed that the promoter amplicons in the JUN-binding sites were significantly enriched by anti-Jun antibody. O, P The expression of Linc01133 was positively correlated with that of c-JUN and c-FOS in gastric cancer tissues (n = 25). Q Representative staining patterns of c-Jun and c-FOS detected by immunohistochemistry in gastric cancer tissues. Each experiment was performed in triplicates. Data are shown as mean ± SD, *P < 0.05, **P < 0.01.